Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
07/2006
07/11/2006US7074819 Benzopyran or thiobenzopyran derivatives
07/11/2006US7074816 Gout; xanthine oxidase inhibitors; reacting iminoether or an aromatic nitrile with hydrazide
07/11/2006US7074809 Exhibiting an activity at metabotropic glutamate receptors (mGluRs), especially at the mGluR5 receptor
07/11/2006US7074801 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof
07/11/2006US7074800 Quinazoline derivatives as angiogenesis inhibitors
07/11/2006US7074799 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity
07/11/2006US7074794 pyrrolo-2yl-carbonyl-amino compounds; dipeptidyl peptidase inhibitor
07/11/2006US7074789 Kinase inhibitors
07/11/2006US7074787 Controlling, prevention plant infections; fungicides, nematocides, insecticides
07/11/2006US7074785 Δ1-pyrrolines used as pesticides
07/11/2006US7074781 E.g., 1-(2-methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-ylcarbonyl)benzylcarbamoyl)-L-proline-N,N-dimethylamide; control of urinary incontinence and bleeding disorders.
07/11/2006CA2285548C Nicotinamide derivatives
07/11/2006CA2260999C Heterocyclic compounds, their production and use in tyrosine kinase inhibition
07/11/2006CA2244870C N,n-disubstituted amic acid derivatives
07/11/2006CA2206532C Novel amidinonaphthyl derivative or salt thereof
07/11/2006CA2158609C 5 .alpha.-reductase inhibitors
07/11/2006CA2125824C Heteroaryl coumarins as inhibitors of leukotriene biosynthesis
07/06/2006WO2006071958A1 Compounds useful as chemokine receptor antagonists
07/06/2006WO2006070927A1 Pyrimidinylisoxazol derivative
07/06/2006WO2006070806A1 Novel benzimidazole compound and medicinal composition containing the compound
07/06/2006WO2006070202A1 Pyrazole derivatives having kinase modulating activity
07/06/2006WO2006070198A1 Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinases
07/06/2006WO2006070001A1 Substituted indole ligands for the orl-1 receptor
07/06/2006WO2006069946A1 Substituted pyrrolidinones having an antithrombotic effect, the production thereof and their use as medicaments
07/06/2006WO2006069788A1 Organic compounds
07/06/2006WO2006069776A1 5-ht7 receptor antagonists
07/06/2006WO2006069775A1 5-ht7 receptor antagonists
07/06/2006WO2006069740A1 2, 5 and 2, 6-disubstituted benzazole analogues useful as protein kinase inhibitors
07/06/2006WO2006069685A1 Substituted oxyarenes
07/06/2006WO2006053227A3 Il-12 modulatory compounds
07/06/2006WO2006047415A3 FACTOR Xa COMPOUNDS
07/06/2006WO2006046123A3 Conjugates with anti-inflammatory activity
07/06/2006WO2006046030A3 Tetracyclic indole derivatives as antiviral agents
07/06/2006WO2006018682A3 Oxazolidinone derivatives as antimicrobials
07/06/2006WO2006005741A3 Piperdine derivatives as renin inhibitors
07/06/2006WO2005116002A3 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
07/06/2006US20060149077 4-Naphthyl-substituted, e.g., 2,2-bis[2-[(4S)-(1-naphthyl)-5,5-dimethyloxazoline]]propane; catalyst for preparing cyclopropanecarboxylates from prochiral olefins; amidating a 1-amino-1-naphthyl-2-(cyclo)alkanol with a dicarboxylate or diacyl halide and cyclizing the diamide formed with a Lewis acid
07/06/2006US20060149059 Phthalazinone derivatives
07/06/2006US20060148879 1-Phenyl-2-oxo-3-sulfonylamino-pyrrolidine derivatives and related compounds as factor xa inhibitors for the treatment of acute vascular diseases
07/06/2006US20060148869 Halogenated biaryl heterocyclic compounds and methods of making and using the same
07/06/2006US20060148868 Zolmitriptan polymorphs
07/06/2006US20060148864 Treating or preventing a disease ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay such as genetic disorders
07/06/2006US20060148863 E.g., 3-[5-(2-Chloro-pyridin-3-yl)-[1,2,4]oxadiazol-3-yl]-benzoic acid; treating or preventing a disease ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay such as genetic disorders
07/06/2006US20060148862 Novel compounds that modulate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof
07/06/2006US20060148858 1, 2-Azole derivatives with hypoglycemic and hypolipidemic activity
07/06/2006US20060148856 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
07/06/2006US20060148834 Novel coumarin-amide derivatives and its preparation, said drug composition and its use
07/06/2006US20060148817 Pyrazole compounds
07/06/2006US20060148798 Antiinflammatory agents; cardiovascular disorders; antidiabetic agents;central nervous system diosrders ; anticancer agents
07/06/2006US20060148797 Benzoyl-tetrahydropiperidine derivatives
07/06/2006US20060148793 beta-aryl-alpha-oxysubstituted alkylcarboxylic acids, usch as Ethyl (E/Z)-3-[4-[2-(phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropenoate, used as antilipemic or hypoglycemic agents
07/06/2006US20060148791 Glutamate receptor antagonists
07/06/2006US20060148779 Calcitonin Gene-Related Peptide (CGRP) antagonists for migraine and cluster headaches; 5'-acylamino-spiro[imidazolidine-4,2'-indane]-2,5-dione derivatives
07/06/2006US20060148649 Substituted n-aryl nitrogen heterocycles
07/06/2006DE102005054092A1 Stereoisomer angereicherte 3-Aminocarbonyl-Bicyclohepten-Pyrimidindiamin-Verbindungen und deren Anwendungen Stereoisomer enriched 3-aminocarbonyl-bicycloheptene pyrimidinediamine compounds and their applications
07/06/2006DE102004062544A1 Neue substituierte Pyrrolidinone, deren Herstellung und deren Verewendung als Arzneimittel New substituted pyrrolidinones, their preparation and their Verewendung as medicaments
07/06/2006DE102004062542A1 Substituierte Oxyarene Substituted Oxyarene
07/06/2006DE102004061751A1 Cyanoguanidin-substituierte Pyrazoline Cyanoguanidino substituted pyrazolines
07/06/2006DE102004061750A1 Heteroaryl-substituierte Pyrazoline Heteroaryl substituted pyrazolines
07/06/2006DE102004061748A1 Azetidin-substituierte Pyrazoline Azetidine-substituted pyrazolines
07/06/2006CA2592514A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
07/06/2006CA2592509A1 Benzazole analogues and uses thereof
07/06/2006CA2592131A1 Substituted pyrrolidinones having an antithrombotic effect, the production thereof and their use as medicaments
07/06/2006CA2591912A1 Pyrimidinylisoxazole derivatives
07/06/2006CA2591201A1 5-ht7 receptor antagonists
07/06/2006CA2590666A1 5-ht7 receptor antagonists
07/06/2006CA2587348A1 Organic compounds
07/05/2006EP1676844A1 5-HT7 receptor antagonists
07/05/2006EP1676840A1 5-HT7 Receptor antagonists
07/05/2006EP1675850A1 Quinoline compounds and their uses
07/05/2006EP1675841A1 Process for preparation of mycophenolate mofetil and other esters of mycophenolic acid
07/05/2006EP1675838A1 1-benzoyl substituted diazepine derivatives as selective histamine h3 receptor agonists
07/05/2006EP1675836A1 Derivatives of 4-phenylthiazoles and 4-phenylimidazoles and the use thereof as medicaments for treating neurodegenerative diseases, pain and epilepsy
07/05/2006EP1675585A2 Large conductance calcium-activated k channel opener
07/05/2006EP1675584A1 Substituted benzazoles and use thereof as inhibitors of raf kinase
07/05/2006EP1399441B1 N-aroyl cyclic amine derivatives as orexin receptor antagonists
07/05/2006EP1385844B1 Oxazolidinones containing a sulfonimid group as antibiotics
07/05/2006EP1250328B1 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
07/05/2006CN1798748A Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
07/05/2006CN1798743A N-alkynyl-2-heteroaryloxyalkylamides for use as fungicides
07/05/2006CN1798738A Biaryl substituted pyrazoles as sodium channel blockers
07/05/2006CN1262551C Substituted oxazolidinones and their use in the field of blood coagulation
07/05/2006CN1262550C Green light spectrum sensitizer, and synthesis method and use thereof
07/05/2006CN1262548C Synthesis of benzoxazine monohydrochlorate compound
07/05/2006CN1262547C Phenyl-and aminophenyl-alkyl sulfonamide and urea derivative
07/05/2006CN1262540C Bicycle androgen and progesterone receptor modulator compounds and methods
07/04/2006US7071332 Indolinone derivatives as protein kinase/phosphatase inhibitors
07/04/2006US7071220 Chymase inhibitor; cardiovascular disorders, circulation diseases; hypotensive agents
07/04/2006US7071216 Anticancer agents
07/04/2006US7071213 Cannabinoid receptor ligands
07/04/2006US7071208 β3 Adrenergic agonists
07/04/2006US7071198 Antiinflamamtory agents; antiarthritic agents; inflammatory bowel disorders; multiple sclerosis; asthma
07/04/2006US7071192 Respiratory system disorders; infections in infants
07/04/2006US7071191 Non-imidazole aryloxypiperidines
07/04/2006US7071189 Heterocyclic compounds as antitumor agents with benzimidazole group and morpholine group, triazoline or pyrimidine heterocycles
07/04/2006US7071182 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
07/04/2006US7071180 Eating disorders; cognition activators; psychological disorders; anxiolytic agents; sexual disorders; incontinence; antidepressants
07/04/2006CA2332066C Tetrazole compounds as thyroid receptor ligands
06/2006
06/29/2006WO2006069277A1 TRICYCLIC δ-OPIOID MODULATORS
06/29/2006WO2006069275A1 Tricyclic delta-opioid modulators